Rebirth of Hong Kong 1981

   Chapter 712 Small target: general agent

   For the next two days, while Yang Chen inspected the work in the US company, he took time to participate in the board of directors of all shareholders of Shire Company initiated by Old Jack.

  He can get the scriptures from the island country for Kampo medicine. Obviously, there is no way for this western medicine. He has to rely on pharmaceutical companies in Europe and the United States such as the US Empire.

   Shire Company is his first step into western medicine. As long as the board of directors approves, then relying on the strength of Shire Company can help him build a modern and first-class pharmaceutical production factory in Xiangjiang.

   Affected by the overall environment of the pharmaceutical industry, Shire's shareholders are still interested in entering the Asian market.

  I'm not interested and I can't do anything about it. The proposal was proposed by Yang Chen, the company's third largest shareholder, and Old Jack, the major shareholder and chairman, agreed.

   Therefore, the other directors of the board of directors did not object to Yang Chen's proposal.

   Even Shire's second largest shareholder did not express any objection to the company's plans to open a branch in Asia.

Thanks to Yang Chen's money offensive, the establishment of the Asian branch, the Shire head office only needs to provide people, prescriptions and other work that does not cost money, and all other expenses are paid by Yang Chen, who is a good money winner. Responsible.

  The head office of Shire takes 40% of the shares of the Asian branch without paying a penny.

   Of course, this is just one of the reasons.

   The reason why everyone accepts Yang Chen's control over the branch and enjoys the final pricing power is that most shareholders do not pay much attention to the current Asian market.

  Although the population of Asia has a great advantage, it is still in the initial stage of development, and many developing countries have never really paid attention to drug patents.

  If you want to sell high-priced medicines, it is simply not feasible, you can only choose small profits but quick turnover.

  Except for fast-growing Asian countries such as island countries and South Korea, most Asian countries have not done a very good job of protecting pharmaceutical patents even in the 21st century.

   The majority of Shire's shareholders mainly focus on the domestic market of the United States, as well as developed countries such as Europe with sound systems.

   If Yang Chen wants to obtain the final pricing power in the developed country market, there is no door, so he doesn't even have to think about it, let alone the shareholders will not agree, I am afraid that even Old Jack will not agree.

   "Boss, Manager Shen is here."

"boss"

   Although it wasn't the first time that Shen Xu had met Yang Chen, it was the first time for such a private meeting, especially the successful listing of Orange Technology in the United States two days ago, which made Yang Chen's worth skyrocket.

   In the face of this new richest man in China, the big boss who rewarded his job, Shen Xu did not dare to be disrespectful.

   "Sit, don't stand."

   "Thank you boss"

   Regardless of Shen Xu's restrained appearance, Huo Jianxuan took out a contract from his briefcase and handed it to Yang Chen.

   "Boss, I persuaded several minority shareholders of Shire to buy the 6% of Shire shares they held.

   From now on, we have a 24% stake in Shire.

This is an equity transfer contract. The shares we hold have exceeded Mr. Ness (the former second shareholder of Shire). If the shares held by Chairman Jack are added, the shares of Shire held by both of us will be Already more than half.

In the future, I think Mr. Jack will not reduce his shareholding. As long as we continue to absorb the shares of Shire and keep our shares not falling by 20%, we will be able to guarantee the future of Asia. The branch was successfully established. "

Yang Chen took the equity transfer book handed over by Huo Jianhuo, glanced at it, and handed it to Shen Xu, who was sitting on the side, and said, "Manager Shen, I think Manager Huo is on the road and has already told you about the matter. say clearly.

   This time I transferred you from Orange Technology to take charge of this matter. I hope you can do it well. Next, I will notify the Shire company, and you will handle the corresponding affairs on my behalf.

   In addition to ensuring that the shares we hold will not decline during the financing process, we also urge the Shire head office to speed up. "

   "If there is a chance, I hope you can persuade all Shire shareholders for me to move Shire's pharmaceutical factory to Asia."

   "Of course, this matter can't be rushed, and there will definitely be no results in a short time, but with the rising labor costs in the United States, many American companies have begun to relocate factories out of the United States.

   And the U.S. government also intends to outsource these factories. We can wait for the opportunity slowly. As long as the opportunity comes, you must seize it. If not, call me and let me know. "

  Shen Xu saw Yang Chen's serious face, he obviously attached great importance to this matter, and he also became interested.

Without waiting for Shen Xu to speak, Yang Chen continued: "By the way, after the branch in Asia is established, you need to go to the American Medical University to help the company search for some top medical talents. We can't only produce , instead of researching new drugs…”

   Yang Chen has always understood a truth.

   That is, what belongs to others is always others, and some things only belong to oneself when one has mastered them.

  This world has never lacked cases of small people counterattacking. For the same reason, the branch office is not necessarily worse than the head office.

   As long as he is willing to invest, in the future, relying on the entire Asian market, he will be on an equal footing with Shire Headquarters, which is not a dream.

   Shire is not a leading company in the US pharmaceutical industry. It is only in the ranks of pharmaceutical companies and ranks relatively high. There are still many excellent pharmaceutical companies in the United States, and Shire's next competitive pressure will be very great.

   On the other hand, Yang Chen’s side is different. The entire Asian market is still being cultivated. Compared with the American market, the competitive pressure will be much lower.

   One and the other went up and down, and he had no pressure on the branch to counterattack.

   In addition, he also holds stocks in other American pharmaceutical companies. As long as it operates well, he can become the general agent of American pharmaceutical companies in Asia.

   Of course, a small agency. It would definitely not satisfy his appetite, even if this agent had control over the pricing power of medicines and the production chain.

   His goal is to build one of the world's top pharmaceutical research institutes to compete with the world's top pharmaceutical companies in the future.

   In other words, he hopes that his future pharmaceutical company can make contributions and benefit all mankind.

  Ahem, well, those things are too far away.

   cannot be accomplished overnight.

   Now, let’s be practical, first set a small goal, build a pharmaceutical factory, and get the title of general agent.

  ——

   (end of this chapter)